Home

Vacaciones Alergia repentino nmd pharma claus olesen futuro ola Flecha

Fremtiden for life science bor i Midtjylland - Debatindlæg - Debat - JP  Aarhus
Fremtiden for life science bor i Midtjylland - Debatindlæg - Debat - JP Aarhus

Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review
Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review

Invitation to invest in Initiator Pharma A/S
Invitation to invest in Initiator Pharma A/S

Claus Olesen – Co-Founder/CEO – Stipe Therapeutics | LinkedIn
Claus Olesen – Co-Founder/CEO – Stipe Therapeutics | LinkedIn

Initiator Pharma
Initiator Pharma

Initiator Pharma | LinkedIn
Initiator Pharma | LinkedIn

Prominent Canadian researcher in Denmark: Why I left a top job in California
Prominent Canadian researcher in Denmark: Why I left a top job in California

Claus Oleson - BioLeader Interview - PIR International
Claus Oleson - BioLeader Interview - PIR International

Claus Oleson - BioLeader Interview - PIR International
Claus Oleson - BioLeader Interview - PIR International

Initiator Pharma
Initiator Pharma

Aarhus Biotech Company takes up the fight against neuromuscular  diseases</a> — NMD Pharma
Aarhus Biotech Company takes up the fight against neuromuscular diseases</a> — NMD Pharma

Initiator Pharma
Initiator Pharma

UNIVERSITY OF COPENHAGEN Project title Development of novel treatments  against myotonia Mentor 1 Pontus Gourdon, MS
UNIVERSITY OF COPENHAGEN Project title Development of novel treatments against myotonia Mentor 1 Pontus Gourdon, MS

Christina Grønberg – University of Copenhagen
Christina Grønberg – University of Copenhagen

Biomedicine researchers' company receives DKK 20 million for muscular  research
Biomedicine researchers' company receives DKK 20 million for muscular research

HITTA ER ET A UN AMI TA ON HI HA UT ME AT THE
HITTA ER ET A UN AMI TA ON HI HA UT ME AT THE

NMD Pharma ApS « Danish Science and The City DKBIO 17 « Solebury Trout  Access
NMD Pharma ApS « Danish Science and The City DKBIO 17 « Solebury Trout Access

COMPOUNDS FOR USE IN TREATING NEUROMUSCULAR DISORDERS - European Patent  Office - EP 3307262 B1
COMPOUNDS FOR USE IN TREATING NEUROMUSCULAR DISORDERS - European Patent Office - EP 3307262 B1

NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn

Initiator Pharma
Initiator Pharma

Founders — NMD Pharma
Founders — NMD Pharma

Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review
Aarhus-biotek tager kampen op mod neuromuskulære sygdomme - Business Review

Soonicorn Club: Top Tech Startups In Denmark To Watch Out For | Tracxn
Soonicorn Club: Top Tech Startups In Denmark To Watch Out For | Tracxn

Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person  Profile
Claus Elsborg Olesen - CBO & Co-Founder @ NMD Pharma - Crunchbase Person Profile

NMD Pharma - Crunchbase Company Profile & Funding
NMD Pharma - Crunchbase Company Profile & Funding

Novo A/S Novo Seeds. Letter from the CEO SYNLAB. Novo Ventures - PDF Free  Download
Novo A/S Novo Seeds. Letter from the CEO SYNLAB. Novo Ventures - PDF Free Download

Claus Elsborg Olesen - Biography
Claus Elsborg Olesen - Biography